
Treatment of soft tissue sarcoma with dendritic cells
Soft tissue sarcomas are rare malignant tumors that develop in muscles, fat, cartilage, blood vessels, and other non-epithelial tissues throughout the body. With approximately 13,520 new cases expected in the United States in 2025, these cancers represent less than 1% of all cancer diagnoses.
While advanced sarcomas differ significantly from other cancers in their origin and behavior, treatment outcomes have steadily improved. Current five-year survival rates reach 66% overall, with localized cases achieving 83% survival rates. For patients facing advanced stages or treatment-resistant…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.